Turpinator, As usual, a splendid and to the point summary. Thank you.
Pardon me everyone, but I have nothing better to do on this long US holiday weekend than to write volumes on this board.
I have to admit that as an American, I am very upbeat about the MFYS opportunites from the perspectives of a long term growth stock persuing fertile socialized medicine market environments (non-US), and also as a currency play to hedge what appears to be a coming dollar collapse.
Dareing to look ahead so far, the US healthcare market, (the IT, and the health administration infrastructure) is sooooo very splintered, and there are so many political and socio-privacy landmines that it is hard to see such systems going in over here anytime soon. We'll see though what the US baby-boomer rush does to our Medicare (or next generation) health system through the political process when they realize that they don't have the money to live as long as they would like to and are capable of. This political can of worms will begin to bust wide open in 2010-11. Should Medify still be around then, it will mean that they have made substantial progress. That could be the ideal set-up for their next licensing opportunity.
Unless of course Microsoft or WalMart dominates the market then.
Thanks,
Herbie